Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOPHARMACEUTICALS INDUSTRY
2.1 Summary about Biopharmaceuticals Industry
2.2 Biopharmaceuticals Market Trends
2.2.1 Biopharmaceuticals Production & Consumption Trends
2.2.2 Biopharmaceuticals Demand Structure Trends
2.3 Biopharmaceuticals Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Monoclonal Antibodies 
4.2.2 Interferon 
4.2.3 Colony-Stimulating Factor 
4.2.4 Erythropoietin 
4.2.5 Insulin 
4.2.6 Vaccines 
4.2.7 Growth Hormones 
4.2.8 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Tumor 
4.3.2 Diabetes 
4.3.3 Cardiovascular 
4.3.4 Hemophilia 
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Monoclonal Antibodies 
5.2.2 Interferon 
5.2.3 Colony-Stimulating Factor 
5.2.4 Erythropoietin 
5.2.5 Insulin 
5.2.6 Vaccines 
5.2.7 Growth Hormones 
5.2.8 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Tumor 
5.3.2 Diabetes 
5.3.3 Cardiovascular 
5.3.4 Hemophilia 
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Monoclonal Antibodies 
6.2.2 Interferon 
6.2.3 Colony-Stimulating Factor 
6.2.4 Erythropoietin 
6.2.5 Insulin 
6.2.6 Vaccines 
6.2.7 Growth Hormones 
6.2.8 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Tumor 
6.3.2 Diabetes 
6.3.3 Cardiovascular 
6.3.4 Hemophilia 
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Monoclonal Antibodies 
7.2.2 Interferon 
7.2.3 Colony-Stimulating Factor 
7.2.4 Erythropoietin 
7.2.5 Insulin 
7.2.6 Vaccines 
7.2.7 Growth Hormones 
7.2.8 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Tumor 
7.3.2 Diabetes 
7.3.3 Cardiovascular 
7.3.4 Hemophilia 
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Monoclonal Antibodies 
8.2.2 Interferon 
8.2.3 Colony-Stimulating Factor 
8.2.4 Erythropoietin 
8.2.5 Insulin 
8.2.6 Vaccines 
8.2.7 Growth Hormones 
8.2.8 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Tumor 
8.3.2 Diabetes 
8.3.3 Cardiovascular 
8.3.4 Hemophilia 
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Monoclonal Antibodies 
9.2.2 Interferon 
9.2.3 Colony-Stimulating Factor 
9.2.4 Erythropoietin 
9.2.5 Insulin 
9.2.6 Vaccines 
9.2.7 Growth Hormones 
9.2.8 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Tumor 
9.3.2 Diabetes 
9.3.3 Cardiovascular 
9.3.4 Hemophilia 
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche 
10.1.2 Amgen 
10.1.3 AbbVie
10.1.4 Sanofi-Aventis 
10.1.5 Johnson & Johnson 
10.1.6 Pfizer 
10.1.7 Novo Nordisk 
10.1.8 Eli Lilly 
10.1.9 Novartis 
10.1.10 Merck
10.2 Biopharmaceuticals Sales Date of Major Players (2017-2020e)
10.2.1 Roche 
10.2.2 Amgen 
10.2.3 AbbVie
10.2.4 Sanofi-Aventis 
10.2.5 Johnson & Johnson 
10.2.6 Pfizer 
10.2.7 Novo Nordisk 
10.2.8 Eli Lilly 
10.2.9 Novartis 
10.2.10 Merck
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Biopharmaceuticals Product Type Overview
Table Biopharmaceuticals Product Type Market Share List
Table Biopharmaceuticals Product Type of Major Players
Table Brief Introduction of Roche 
Table Brief Introduction of Amgen 
Table Brief Introduction of AbbVie
Table Brief Introduction of Sanofi-Aventis 
Table Brief Introduction of Johnson & Johnson 
Table Brief Introduction of Pfizer 
Table Brief Introduction of Novo Nordisk 
Table Brief Introduction of Eli Lilly 
Table Brief Introduction of Novartis 
Table Brief Introduction of Merck
Table Products & Services of Roche 
Table Products & Services of Amgen 
Table Products & Services of AbbVie
Table Products & Services of Sanofi-Aventis 
Table Products & Services of Johnson & Johnson 
Table Products & Services of Pfizer 
Table Products & Services of Novo Nordisk 
Table Products & Services of Eli Lilly 
Table Products & Services of Novartis 
Table Products & Services of Merck
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Biopharmaceuticals Market Forecast (Million USD) by Region 2021f-2026f
Table Global Biopharmaceuticals Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Biopharmaceuticals Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Biopharmaceuticals Market Forecast (Million USD) Share by Demand 2021f-2026f